Xerox raises $24 billion from banks to support acquisition of HP
Category: #headlines  By Saipriya Iyer  Date: 2020-01-07
  • share
  • Twitter
  • Facebook
  • LinkedIn
Xerox raises $24 billion from banks to support acquisition of HP
  • Xerox received funds from leading financial institutions such as Citi Bank, Bank of America and Mizuho
     
  • The proposed merger will help both the companies save costs up to USD 2 billion over two years

Prominent American corporation Xerox, that sells print and digital document products and services across 160 countries, has reportedly bolstered its bid to acquire its larger rival HP for a total valuation of US$33 billion, after receiving US$24 billion in financing from leading banks.

In a public statement released by the CEO of Xerox- John Visentin to the board of members of HP, the company has confirmed that it has obtained nearly USD 24 billion in financing from leading financial associations like the Bank of America, Mizuho and Citi Bank.

Earlier, HP was skeptical about Xerox’s financing ability, however, now by raising huge public funds the company has resolved one of the biggest obstacles in place. The latest funding may boost the confidence of the shareholders, who were previously non-supportive of the deal, to now consider Xerox’s proposal.

Reportedly, both HP and Xerox have been at odds since November when Xerox made various unsolicited bids that were rejected by the board of directors of HP. The rejection drove Xerox to take its offer directly to the shareholders of HP.

Apparently, Xerox has proposed a merger between the companies calling it a that will potentially save both companies close to US$2 billion in costs over the period of next two years and result in revenue growth of nearly US$1.5 billion in the next three years.

However, HP board has concerns regarding the collaboration, questioning the 10% decline in revenue of Xerox since last year and considering that a combined firm may possess too much debt.

The takeover bid is announced after Xerox retailed off its £2.3 billion worth of stake in Fuji Xerox to Japanese company Fujifilm, ending a dispute between the companies. Fujifilm will halt its office equipment sales partnership with Xerox in the year 2021.

 

Source Credits: https://www.forbes.com/sites/sergeiklebnikov/2020/01/06/xerox-secures-24-billion-for-hostile-takeover-bid-of-hp/#45def1beb4d6

  • share
  • Twitter
  • Facebook
  • LinkedIn

About Author

Saipriya Iyer

Saipriya Iyer    

Saipriya Iyer currently works as a content developer for GroundAlerts. A computer engineer by profession, she ventured into the field of writing for the love of playing with words. Having had previous experience of 3 years under her belt, she has dabbled with website ...

Read More >>

More News By Saipriya Iyer

Global Wooden Furniture Market by Key Players, Countries, Segments and Application, Forecast to 2027
Global Wooden Furniture Market by Key Players, Countries, Segments and Application, Forecast to 2027
By Saipriya Iyer

Global wooden furniture market is poised to witness a tremendous growth over the projected timeframe of 2020 to 2026 on account of rising number of residential and commercial construction activities across the globe. Alongside, increasing consumer in...

Cladribine Market Growth Manufacturers, Regions, Product Types, Major Application Analysis & Forecast To 2026
Cladribine Market Growth Manufacturers, Regions, Product Types, Major Application Analysis & Forecast To 2026
By Saipriya Iyer

Global Cladribine Market Research Report: Size, Share, Trends, Industry Growth, Opportunity, Application, Production, Segmentation, Cost Structure, Company Profile, Product Picture and Specifications during the Forecast period by 2026 Executive summ...

Cardiovascular Disease Drugs Market size and Key Trends in terms of volume and value 2021-2026
Cardiovascular Disease Drugs Market size and Key Trends in terms of volume and value 2021-2026
By Saipriya Iyer

Global Cardiovascular Disease Drugs ?Market report 2026 focuses on the major Types and Applications for the key players. Global Cardiovascular Disease Drugs market research report also provides analysis of the market share, segmentation, revenue fore...